Figure 4From: TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages Proapoptotic activities of TRIAL and MG133 combination treatment. Treatment with 10–20 ng/ml TRAIL and 0.5-1 μM MG132 combination reduces protein level for both phospho- and non-phospho-Akt in NCI-H28 cells, as revealed by Western blotting at 24 h after treatment.Back to article page